Title:
TAM FAMILY KINASE /AND CSF1R KINASE INHIBITOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2019/141202
Kind Code:
A9
Abstract:
Disclosed is a new inhibitor compound as shown in general formula (I). The compound has a good kinase inhibitory activity. The compound of formula (I) can be used for preventing and/or treating diseases mediated by abnormal expression of TAM family kinase receptors and/or ligands thereof. In addition, the compound also can target a CSF1R kinase, and can be used for preventing and/or treating diseases mediated by abnormal expression of TAM family kinase receptors /and CSF1R kinase receptors and/or ligands thereof.
Inventors:
WU FRANK (CN)
LI LIN (CN)
WAN ZHONGHUI (CN)
LI LIN (CN)
WAN ZHONGHUI (CN)
Application Number:
PCT/CN2019/072083
Publication Date:
August 29, 2019
Filing Date:
January 17, 2019
Export Citation:
Assignee:
NANJING TRANSTHERA BIOSCIENCES CO LTD (CN)
International Classes:
C07D405/14; A61K31/501; A61P35/00; C07D401/12; C07D491/04
Attorney, Agent or Firm:
CHINA PATENT AGENT (H.K.) LTD. (CN)
Download PDF: